Topics
CME/CE
Editorial Board
Drug Watch: What's Coming in Acne Treatment?
In this drug pipeline interview, Christopher Bunick, MD, PhD, discusses what is innovative in future acne treatment options, what research is happening, and what potential approvals the dermatology space has to look forward to.
Christopher Bunick, MD, PhD, Dermatology Times® editorial board member and physician-scientist practicing general medical and surgical dermatology at Yale University, in New Haven, Connecticut, dives into the acne drug pipeline. Hear his notes on what potenital new treatments are coming for acne vulgaris, exciting research advancements in the space, and much more.
Related Videos
Related Content
